MC
CORZ icon

Metavasi Capital’s Core Scientific CORZ Stock Holding History

Metavasi Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-125,000
Closed -$905K – 34
2025
Q1 		$905K Sell
125,000
-95,000
-43% -$1.08M 0.57% 22
2024
Q4 		$3.09M Sell
220,000
-70,000
-24% -$1.03M 1.09% 22
2024
Q3 		$3.44M Buy
290,000
+90,000
+45% +$933K 1.56% 23
2024
Q2 		$1.86M Buy
+200,000
New +$1.02M 0.98% 30

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Metavasi Capital's CORZ Position: Q2 2025 in Review

Metavasi Capital sold out of Core Scientific (CORZ) in Q2 2025, closing a stake of 125,000 shares — an estimated $905K sold.

Metavasi Capital first reported a position in CORZ in Q2 2024 and held it in 4 quarters. The position peaked at $3.44M in Q3 2024. 370 funds tracked by Wall St. Rank hold CORZ as of Q2 2025.

  • Metavasi Capital reported no remaining Core Scientific position as of Q2 2025 after selling out during the quarter.
  • Metavasi Capital sold 125,000 Core Scientific shares in Q2 2025, an estimated $905K.
  • Metavasi Capital first reported a position in Core Scientific in Q2 2024 and held it in 4 quarters.
  • Metavasi Capital's Core Scientific position peaked at $3.44M in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Core Scientific as of Q2 2025.

Based on Metavasi Capital's 13F filing for Q2 2025, filed 14 Aug 2025.